Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Activated LEF/TCF complexes are crucial for hair development and cycling.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Mutations in the HEPHL1 gene cause abnormal hair and cognitive issues.

MAEG helps in mouse hair follicle development by aiding cell adhesion.

Activating ALDH2 can boost hair growth.

miR-5110 affects alpaca pigmentation by altering specific gene expressions.

ALP and ACP have different roles in dog skin, with ALP aiding growth and maintenance, and ACP involved in breakdown processes.

The enzyme pyruvate kinase M2 helps hair regrowth and could be a potential treatment for hair loss.

MAP-2 is crucial for the structure of hair follicles and nails.

A new gene, mrp4, is found in mice and may play a unique role in hair follicle development in tails and ears.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

The LEF-1 binding site enhances gene expression in hair follicles, with other proteins aiding specific regulation.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

The LMNA mutation affects skin structure even in asymptomatic carriers.

Mutations in Far2 mice cause hair loss due to sebaceous gland issues.

The Thr1022Ala variant in the hairless gene is not a disease-causing mutation.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

A genetic marker linked to a type of hair loss was found in most patients studied.

Impaired LEF1 activation speeds up skin cell development in Hutchinson-Gilford Progeria Syndrome.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

Modulating the BTNL2 pathway can prevent hair loss in mice.

Alpha-MSH affects mitochondrial function, and MC1R mutations may increase skin aging.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Faulty LEF1 activation causes faster skin cell differentiation in premature aging syndrome.

Mettl3 is essential for normal tissue development and self-renewal by regulating gene expression.